Trial Profile
A Multicenter, Open-Label, Randomized, Phase 1B Study Evaluating the Safety and Tolerability of Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) in Liver Transplant Recipients
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Mannose binding lectin (Primary)
- Indications Infections
- Focus Adverse reactions
- Sponsors Enzon Pharmaceuticals
- 18 Sep 2014 New trial record